Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Momoko Okuda"'
Autor:
Hiroyuki Aburatani, Mika Kamata-Sakurai, Shinya Ishii, Takayuki Kamikawa, Naoki Kimura, Masaru Muraoka, Kenji Taniguchi, Ryo Uchikawa, Moe Yoshimoto, Momoko Okuda-Miura, Sho Akai, Tatsushi Kodama, Hirofumi Sakumoto, Shigeto Kawai, Mei Shimada, Takehisa Kitazawa, Tomoyuki Igawa
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c4815bc2d9dc4f248da4bb54d50337e2
Autor:
Taichi Kuramochi, Siok Wan Gan, Adrian W.S. Ho, Bei Wang, Nagisa Kageji, Takeru Nambu, Sayaka Iida, Momoko Okuda-Miura, Wei Shan Chia, Chiew Ying Yeo, Dan Chen, Wen-Hsin Lee, Eve Zi Xian Ngoh, Siti Nazihah Mohd Salleh, Cheng-I Wang, Tomoyuki Igawa, Hideaki Shimada
Publikováno v:
mAbs, Vol 14, Iss 1 (2022)
The emergence of escape variants of SARS-CoV-2 carrying mutations in the spike protein poses a challenge for therapeutic antibodies. Here, we show that through the comprehensive engineering of the variable region of the neutralizing monoclonal antibo
Externí odkaz:
https://doaj.org/article/1a9e05e13f4e446f8534b926aad0b052
Autor:
Hiroyasu Muramatsu, Taichi Kuramochi, Hitoshi Katada, Atsunori Ueyama, Yoshinao Ruike, Ken Ohmine, Meiri Shida-Kawazoe, Rie Miyano-Nishizawa, Yuichiro Shimizu, Momoko Okuda, Yuji Hori, Madoka Hayashi, Kenta Haraya, Nobuhiro Ban, Tatsuya Nonaka, Masaki Honda, Hidetomo Kitamura, Kunihiro Hattori, Takehisa Kitazawa, Tomoyuki Igawa, Yoshiki Kawabe, Junichi Nezu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract Myostatin, a member of the transforming growth factor-β superfamily, is an attractive target for muscle disease therapy because of its role as a negative regulator of muscle growth and strength. Here, we describe a novel antibody therapeuti
Externí odkaz:
https://doaj.org/article/f5532204ebd94faaa523b4801829ed1c
Autor:
Yuri Teranishi-Ikawa, Tetsuhiro Soeda, Hikaru Koga, Kazuki Yamaguchi, Kazuki Kato, Keiko Esaki, Kentaro Asanuma, Miho Funaki, Mina Ichiki, Yuri Ikuta, Shunsuke Ito, Eri Joyashiki, Shun-Ichiro Komatsu, Atsushi Muto, Kei Nishimura, Momoko Okuda, Hisakazu Sanada, Motohiko Sato, Norihito Shibahara, Tetsuya Wakabayashi, Koji Yamaguchi, Akiko Matsusaki, Zenjiro Sampei, Hirotake Shiraiwa, Hiroko Konishi, Yoshiki Kawabe, Kunihiro Hattori, Takehisa Kitazawa, Tomoyuki Igawa
Emicizumab, a factor (F)VIIIa-function mimetic bispecific antibody (BsAb) to FIXa and FX, has become an indispensable treatment for people with hemophilia A (PwHA). Although emicizumab is very potent, long-term outcomes from the clinical studies sugg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65e05c434bee4d4affb01dcc8f26f39e
https://doi.org/10.1101/2022.12.19.520692
https://doi.org/10.1101/2022.12.19.520692
Autor:
Meiri Shida-Kawazoe, Yoshinao Ruike, Kenta Haraya, Nobuhiro Ban, Ken Ohmine, Tomoyuki Igawa, Atsunori Ueyama, Hiroyasu Muramatsu, Yuji Hori, Yuichiro Shimizu, Rie Miyano-Nishizawa, Takehisa Kitazawa, Masaki Honda, Madoka Hayashi, Jun-ichi Nezu, Hidetomo Kitamura, Yoshiki Kawabe, Kunihiro Hattori, Momoko Okuda, Taichi Kuramochi, Tatsuya Nonaka, Hitoshi Katada
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Scientific Reports
Scientific Reports
Myostatin, a member of the transforming growth factor-b superfamily, is an attractive target for muscle disease therapy because of its role as a negative regulator of muscle growth and strength. Here, we describe a novel antibody therapeutic approach
Autor:
Takahiro Watanabe-Nakayama, Hideki Taguchi, Yousuke Kikuchi, Momoko Okuda, Noriyuki Kodera, Hiroki Konno, Liwen Zhu, Takayuki Uchihashi, Toshio Ando
Publikováno v:
Proc Natl Acad Sci U S A
The yeast prion protein Sup35, which contains intrinsically disordered regions, forms amyloid fibrils responsible for a prion phenotype [ PSI + ]. Using high-speed atomic force microscopy (HS-AFM), we directly visualized the prion determinant domain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a2a2454c4d4b739bf3d9885b4e2d648
https://europepmc.org/articles/PMC7149427/
https://europepmc.org/articles/PMC7149427/
Autor:
Shinji Matsunaga, Nakao Iwata, Kaku Akamatsu, Tomo Okochi, Hideaki Tabuse, Taro Kishi, Masatsugu Moriwaki, Toshihiko Funahashi, Shigeki Hirano, Kiyoshi Fujita, Yoichiro Otake, Yuki Matsuda, Momoko Okuda
Publikováno v:
Neuropsychiatric Disease and Treatment
Taro Kishi,1 Yuki Matsuda,1 Shinji Matsunaga,1 Masatsugu Moriwaki,1,2 Yoichiro Otake,2 Kaku Akamatsu,3 Tomo Okochi,4 Shigeki Hirano,4 Toshihiko Funahashi,5 Momoko Okuda,6 Hideaki Tabuse,6 Kiyoshi Fujita,2 Nakao Iwata1 1Department of Psychiatry, Fujit
Autor:
Yoshika Iwata1 iwataysk@chugai-pharm.co.jp, Hitoshi Katada2, Momoko Okuda2, Yoshiaki Doi3, Tim Jang Ching2, Asako Harada1, Akira Takeiri1, Masaki Honda1, Masayuki Mishima1
Publikováno v:
Journal of Toxicological Sciences. Jul2023, Vol. 48 Issue 7, p399-409. 11p.
Publikováno v:
Journal of Biological Chemistry. 290(No. 12):7833-7840
Hsp104 solubilizes protein aggregates in cooperation with Hsp70/40. Although the framework of the disaggregase function has been elucidated, the actual process of aggregate solubilization by Hsp104-Hsp70/40 remains poorly understood. Here we develope
Autor:
Hideaki Tabuse, Shinji Matsunaga, Nakao Iwata, Taro Kishi, Toshihiko Funahashi, Momoko Okuda, Ichiro Yasue, Kaku Akamatsu, Yusuke Kajio, Tomo Okochi, Shigeki Hirano, Kei Ino, Tomohiko Mukai, Kiyoshi Fujita, Yuki Matsuda
Publikováno v:
Comprehensive Psychiatry, Vol 59, Iss, Pp 91-97 (2015)
We conducted a cross-sectional survey to assess the prevalence of physical pain in Japanese major depressive disorder (MDD) and schizophrenia (SZ) patients as well as in healthy controls (HCs). We also examined the association between their psychopat